Notice 28 Apr 2025 compliance, manufacturing, pharmaceutical industry, drug regulation, dea, controlled substances

💊Bulk Manufacturer Registration Application by Pisgah Laboratories

Pisgah Laboratories has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 28 Apr 2025 compliance, healthcare, regulations, pharmaceuticals, dea, controlled substances

💊Siemens Healthcare Diagnostics Applies for Controlled Substances Registration

Siemens Healthcare Diagnostics, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 25 Apr 2025 compliance, regulation, pharmaceutical industry, usa, importation, dea, controlled substances

💊DEA Notice on Royal Emerald Pharmaceuticals' Import Application

Royal Emerald Pharmaceuticals has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 25 Apr 2025 healthcare compliance, controlled substances, drug enforcement administration, illinois, medical licensing, state regulation

⚖️Implications of DEA Registration Revocation for Medical Practitioners

The Drug Enforcement Administration (DEA) issued an order revoking the registration of Syed Warsi, M.D., due to the suspension of his medical license in Illinois. This decision, based on the authority of federal and state laws, emphasizes the critical need for practitioners to maintain valid licenses to handle controlled substances, impacting compliance within the healthcare sector.

Learn More
Notice 25 Apr 2025 compliance, regulation, pharmaceuticals, controlled substances, drug enforcement, specgx llc

💊DEA Notice

SpecGx LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 25 Apr 2025 pennsylvania, business compliance, pharmacy regulations, dea, controlled substances, drug enforcement

💊DEA Revokes Registrations of Multiple Pennsylvania Pharmacies

The DEA issued an Order to Show Cause and Immediate Suspension of Registrations to several pharmacies, alleging violations related to the dispensing and recordkeeping of controlled substances. The findings indicate significant discrepancies in record management, endangering public health, and leading to potential revocation of their registration for the sale of drugs.

Learn More
Notice 23 Apr 2025 compliance, healthcare, regulation, pharmaceuticals, dea, controlled substances, drug enforcement, business consequences

⚖️DEA Revocation Decision Impacting De Novo Services, LLC

The Drug Enforcement Administration (DEA) has issued an order revoking the registration of De Novo Services, LLC due to substantial violations in managing controlled substances and maintaining proper recordkeeping. The decision underscores the stringent compliance requirements enforced by federal regulations to protect public health and safety, highlighting the consequences of non-adherence.

Learn More
Notice 18 Apr 2025 regulatory compliance, manufacturing, pharmaceutical industry, controlled substances, drug enforcement

💊Patheon API Services Inc. Applies for Controlled Substances Registration

Patheon API Services Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 18 Apr 2025 compliance, pharmaceuticals, clinical trials, dea, controlled substances, drug enforcement, myonex llc

💊Notice of Application for Controlled Substances by Myonex LLC

Myonex LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 18 Apr 2025 compliance, united states, pharmaceuticals, manufacturing, controlled substances, drug enforcement, business registration

💊DEA Notice

Research Triangle Institute has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More